Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer

about

Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer

Item

http://www.wikidata.org/entity/Q56969146

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 2018

@uk

name

Association of BRAF Mutations ...... static Colorectal Liver Cancer

@en

Association of BRAF Mutations ...... static Colorectal Liver Cancer

@nl

type

Item

label

Association of BRAF Mutations ...... static Colorectal Liver Cancer

@en

Association of BRAF Mutations ...... static Colorectal Liver Cancer

@nl

prefLabel

Association of BRAF Mutations ...... static Colorectal Liver Cancer

@en

Association of BRAF Mutations ...... static Colorectal Liver Cancer

@nl

P1476

Association of BRAF Mutations ...... static Colorectal Liver Cancer

@en

P2093

Andrea Beer

http://www.w3.org/2001/XMLSchema#string

Armin Gerger

http://www.w3.org/2001/XMLSchema#string

Carsten Kamphues

http://www.w3.org/2001/XMLSchema#string

Christoph Schwarz

http://www.w3.org/2001/XMLSchema#string

Christopher L Wolfgang

http://www.w3.org/2001/XMLSchema#string

Doris Wagner

http://www.w3.org/2001/XMLSchema#string

Federico N Aucejo

http://www.w3.org/2001/XMLSchema#string

George Poultsides

http://www.w3.org/2001/XMLSchema#string

Georgios Antonios Margonis

http://www.w3.org/2001/XMLSchema#string

Inger Marie Løes

http://www.w3.org/2001/XMLSchema#string

P2860

Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF

Impact of somatic mutations on patterns of metastasis in colorectal cancer

Mutations of the BRAF gene in human cancer

Concordant analysis of KRAS, BRAF, PIK3CA mutations, and PTEN expression between primary colorectal cancer and matched metastases

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

BRAF vs RAS oncogenes: are mutations of the same pathway equal? Differential signalling and therapeutic implications

Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status

Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database.

Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions

P304

e180996

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMASURG.2018.0996

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

153

http://www.w3.org/2001/XMLSchema#string

P50

Per Eystein Lønning

Timothy Pawlik

P577

2018-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29799910

http://www.w3.org/2001/XMLSchema#string

P932

6137519

http://www.w3.org/2001/XMLSchema#string